Facebook Bans Ads “Discouraging” Vaccination
Facebook has announced that the company is implementing a new global policy banning paid advertisements on its platform that it has determined discourage people from getting vaccinated.1 According to a blog authored by Kang-Xing Jin, Head of Health and Rob Leathern, Director of Product Management at Facebook: Today, we’re launching a new global policy that […]
Mom Fights to Improve Vaccine Injury Program After Daughter’s Death
If you want to get vaccinated, I certainly think you should have the right. But don’t look for Karen Cain at the pharmacy when the COVID-19 vaccine becomes available. Cain is an anti-vaxxer. Her daughter Lauren lived with daily debilitating seizures for 15 years after receiving a bad DPT vaccine as a newborn. It was […]
Flu Shot Deaths in South Korea Said to Be “Coincidental”
Story Highlights More than 80 people have died in South Korea following influenza vaccination. After an investigation into the safety of the vaccines, South Korean health authorities ruled the deaths as “coincidental.” The public health agency in South Korea has decided to continue and promote its free influenza vaccine program despite public anxiety relating to […]
How COVID-19 Vaccine Trials are Designed
There’s been a lot of talk lately about whether or not the fast-tracked COVID-19 vaccine will in fact be safe and effective. While vaccine makers insist that any vaccine reaching the market will have undergone rigorous testing, the way trial protocols are designed suggests these vaccines may leave a lot to be desired. As reported1 by […]
New York Bar Calls for COVID-19 Vaccine Mandate and Promotion
Opinion | The New York State Bar Association (NYSBA) House of Delegates approved resolutions on Nov. 7, 2020 that included urging the state to consider mandating a COVID-19 vaccine once “scientific consensus” emerges that it is safe, effective and necessary.1 The NYSBA also called for a number of other legal reforms and public health measures related […]
CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events
Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its experimental CVnCoV vaccine COVID-19. The vaccine, which was given to more than 250 healthy adults 18 to 60 years of age, is based on messenger ribonucleic acid (mRNA) technology.1 2 Unlike traditional vaccines, mRNA vaccines […]